Process View
Any process that modulates the frequency, rate or extent of bone mineralization.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of bone mineralization"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
CCR5 | chemokine (C-C motif) receptor 5 | 1.000 | Human | |
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.999 | Human | |
CCL5 | chemokine (C-C motif) ligand 5 | 0.997 | Human | |
BMPR1A | bone morphogenetic protein receptor, type IA | 0.994 | ||
SMAD2 | SMAD family member 2 | 0.980 | ||
BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.967 | ||
BMP2 | bone morphogenetic protein 2 | 0.961 | ||
TGFB1 | transforming growth factor, beta 1 | 0.928 | ||
FSTL1 | follistatin-like 1 | 0.901 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.886 | Human | |
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.826 | ||
ENG | endoglin | 0.813 | ||
FKBP1A | FK506 binding protein 1A, 12kDa | 0.805 | ||
WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.716 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.689 | ||
TGFB3 | transforming growth factor, beta 3 | 0.666 | ||
IFNG | interferon, gamma | 0.651 | ||
RUNX1 | runt-related transcription factor 1 | 0.636 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.630 | Human | |
BMPR1B | bone morphogenetic protein receptor, type IB | 0.625 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.612 | Human | |
TJP1 | tight junction protein 1 (zona occludens 1) | 0.560 | ||
CCL3 | chemokine (C-C motif) ligand 3 | 0.558 | ||
IL2RB | interleukin 2 receptor, beta | 0.554 | ||
SETD8 | SET domain containing (lysine methyltransferase) 8 | 0.547 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.543 | Human | |
GDF5 | growth differentiation factor 5 | 0.467 | Human | |
CCL2 | chemokine (C-C motif) ligand 2 | 0.425 | Human | |
SMAD7 | SMAD family member 7 | 0.413 | ||
VCAN | versican | 0.345 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.314 | Human | |
DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.305 | ||
KDM2B | lysine (K)-specific demethylase 2B | 0.267 | ||
CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.256 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.248 | Human | |
CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.236 | Human | |
IRF4 | interferon regulatory factor 4 | 0.232 | ||
CCL19 | chemokine (C-C motif) ligand 19 | 0.224 | Human | |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.215 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.215 | ||
IL10 | interleukin 10 | 0.214 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.211 | ||
CCR2 | chemokine (C-C motif) receptor 2 | 0.209 | Human | |
WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.189 | ||
BMP4 | bone morphogenetic protein 4 | 0.187 | ||
CCL7 | chemokine (C-C motif) ligand 7 | 0.185 | Human | |
CCL11 | chemokine (C-C motif) ligand 11 | 0.183 | Human | |
TM4SF1 | transmembrane 4 L six family member 1 | 0.181 | ||
GATA2 | GATA binding protein 2 | 0.174 | ||
SPRR2A | small proline-rich protein 2A | 0.174 | ||
COL11A2 | collagen, type XI, alpha 2 | 0.158 | ||
SMAD1 | SMAD family member 1 | 0.156 | ||
CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.138 | Human | |
PTPRA | protein tyrosine phosphatase, receptor type, A | 0.130 | ||
MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.124 | ||
SRCIN1 | SRC kinase signaling inhibitor 1 | 0.122 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.121 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.119 | ||
TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.111 | ||
NOG | noggin | 0.106 | ||
MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.105 | ||
PRKG1 | protein kinase, cGMP-dependent, type I | 0.105 | ||
ARRDC3 | arrestin domain containing 3 | 0.103 | ||
RGS1 | regulator of G-protein signaling 1 | 0.090 | ||
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.089 | ||
IL1B | interleukin 1, beta | 0.086 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.086 | ||
CD40LG | CD40 ligand | 0.083 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.082 | ||
PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 0.081 | ||
IL8 | interleukin 8 | 0.080 | ||
EP300 | E1A binding protein p300 | 0.076 | ||
SLAMF7 | SLAM family member 7 | 0.075 | ||
GABARAPL2 | GABA(A) receptor-associated protein-like 2 | 0.073 | ||
ACVR1 | activin A receptor, type I | 0.073 | ||
CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.069 | Human | |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.069 | ||
EPAS1 | endothelial PAS domain protein 1 | 0.068 | ||
MATK | megakaryocyte-associated tyrosine kinase | 0.067 | ||
CCR9 | chemokine (C-C motif) receptor 9 | 0.065 | Human | |
IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.061 | ||
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.061 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.061 | ||
KAT2B | K(lysine) acetyltransferase 2B | 0.060 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.060 | ||
TGFBR1 | transforming growth factor, beta receptor 1 | 0.059 | Human | |
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.058 | ||
WNT2 | wingless-type MMTV integration site family member 2 | 0.054 | Human | |
ACVR2B | activin A receptor, type IIB | 0.053 | ||
DNM1 | dynamin 1 | 0.053 | ||
CCR8 | chemokine (C-C motif) receptor 8 | 0.053 | Human | |
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.050 | Human | |
MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.048 | ||
NRP1 | neuropilin 1 | 0.047 | ||
KCTD1 | potassium channel tetramerisation domain containing 1 | 0.045 | ||
PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.045 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.044 | ||
IL1F5 | interleukin 1 family, member 5 (delta) | 0.043 | ||
FOXF2 | forkhead box F2 | 0.042 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.041 | ||
GDNF | glial cell derived neurotrophic factor | 0.040 | ||
IL4 | interleukin 4 | 0.039 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.039 | ||
IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.039 | ||
TLX1 | T-cell leukemia homeobox 1 | 0.038 | ||
INHBA | inhibin, beta A | 0.038 | ||
PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.038 | ||
TGFBR3 | transforming growth factor, beta receptor III | 0.037 | ||
ALB | albumin | 0.036 | ||
WNT1 | wingless-type MMTV integration site family, member 1 | 0.036 | Human | |
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.036 | ||
SH3BP4 | SH3-domain binding protein 4 | 0.035 | ||
APP | amyloid beta (A4) precursor protein | 0.035 | ||
FGF18 | fibroblast growth factor 18 | 0.034 | ||
SMAD9 | SMAD family member 9 | 0.034 | ||
IL21R | interleukin 21 receptor | 0.034 | ||
IDE | insulin-degrading enzyme | 0.034 | ||
CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.034 | ||
HDAC9 | histone deacetylase 9 | 0.034 | ||
CCR6 | chemokine (C-C motif) receptor 6 | 0.033 | Human | |
MEF2A | myocyte enhancer factor 2A | 0.033 | ||
ESR1 | estrogen receptor 1 | 0.033 | ||
EGLN3 | egl nine homolog 3 (C. elegans) | 0.033 | ||
MYOD1 | myogenic differentiation 1 | 0.032 | ||
VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.032 | ||
SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.032 | ||
CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.031 | Human | |
COL2A1 | collagen, type II, alpha 1 | 0.030 | ||
IL6R | interleukin 6 receptor | 0.030 | ||
TNF | tumor necrosis factor | 0.030 | ||
SMAD6 | SMAD family member 6 | 0.030 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.029 | ||
FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.029 | ||
IL1A | interleukin 1, alpha | 0.028 | ||
SNAPIN | SNAP-associated protein | 0.028 | ||
SOX1 | SRY (sex determining region Y)-box 1 | 0.028 | ||
HAND2 | heart and neural crest derivatives expressed 2 | 0.028 | Human | |
EBI3 | Epstein-Barr virus induced 3 | 0.027 | ||
UBR4 | ubiquitin protein ligase E3 component n-recognin 4 | 0.026 | ||
PLA2G2D | phospholipase A2, group IID | 0.026 | ||
MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.026 | ||
CCL1 | chemokine (C-C motif) ligand 1 | 0.026 | Human | |
CCL20 | chemokine (C-C motif) ligand 20 | 0.026 | Human | |
LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.025 | ||
SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.025 | ||
PDCD1 | programmed cell death 1 | 0.025 | ||
CD86 | CD86 molecule | 0.025 | ||
EPHB2 | EPH receptor B2 | 0.025 | ||
TCF12 | transcription factor 12 | 0.025 | ||
PTEN | phosphatase and tensin homolog | 0.024 | ||
SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.024 | ||
SFRP1 | secreted frizzled-related protein 1 | 0.024 | ||
NEUROG2 | neurogenin 2 | 0.024 | Human | |
IL18RAP | interleukin 18 receptor accessory protein | 0.024 | ||
FGF3 | fibroblast growth factor 3 | 0.023 | ||
IL13 | interleukin 13 | 0.022 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.022 | ||
RUNX2 | runt-related transcription factor 2 | 0.022 | ||
FZD7 | frizzled homolog 7 (Drosophila) | 0.022 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.022 | ||
TBX21 | T-box 21 | 0.021 | ||
SHOX2 | short stature homeobox 2 | 0.021 | ||
GABARAPL1 | GABA(A) receptor-associated protein like 1 | 0.021 | ||
GAB2 | GRB2-associated binding protein 2 | 0.020 | ||
CD80 | CD80 molecule | 0.020 | ||
IL7R | interleukin 7 receptor | 0.020 | ||
LAG3 | lymphocyte-activation gene 3 | 0.020 | ||
SELE | selectin E | 0.020 | ||
CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.020 | Human | |
WIF1 | WNT inhibitory factor 1 | 0.019 | ||
IHH | Indian hedgehog | 0.019 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.019 | ||
CCL21 | chemokine (C-C motif) ligand 21 | 0.019 | ||
FPR3 | formyl peptide receptor 3 | 0.019 | ||
FOXF1 | forkhead box F1 | 0.019 | ||
SIX6 | SIX homeobox 6 | 0.019 | ||
IL2RA | interleukin 2 receptor, alpha | 0.019 | ||
MMP19 | matrix metallopeptidase 19 | 0.018 | ||
INSR | insulin receptor | 0.018 | ||
PITPNM3 | PITPNM family member 3 | 0.018 | ||
EFS | embryonal Fyn-associated substrate | 0.018 | ||
EVI2B | ecotropic viral integration site 2B | 0.018 | ||
GAS1 | growth arrest-specific 1 | 0.018 | ||
NELL1 | NEL-like 1 (chicken) | 0.018 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.018 | ||
IL11 | interleukin 11 | 0.018 | ||
HEYL | hairy/enhancer-of-split related with YRPW motif-like | 0.018 | ||
HTR4 | 5-hydroxytryptamine (serotonin) receptor 4 | 0.018 | ||
ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.018 | ||
PRKACB | protein kinase, cAMP-dependent, catalytic, beta | 0.018 | ||
FOXB1 | forkhead box B1 | 0.018 | ||
DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.018 | ||
CLEC7A | C-type lectin domain family 7, member A | 0.018 | ||
HOXC8 | homeobox C8 | 0.017 | ||
SOD3 | superoxide dismutase 3, extracellular | 0.017 | ||
KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.017 | ||
ALX4 | ALX homeobox 4 | 0.017 | ||
LNX1 | ligand of numb-protein X 1 | 0.017 | ||
PTK2 | PTK2 protein tyrosine kinase 2 | 0.017 | ||
FGF4 | fibroblast growth factor 4 | 0.017 | ||
CCR3 | chemokine (C-C motif) receptor 3 | 0.017 | Human | |
LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.017 | ||
NRP2 | neuropilin 2 | 0.017 | ||
CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.017 | ||
EGFL6 | EGF-like-domain, multiple 6 | 0.017 | ||
DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.017 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.016 | ||
DARC | Duffy blood group, chemokine receptor | 0.016 | ||
SLC9A3 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 | 0.016 | ||
EFNB3 | ephrin-B3 | 0.016 | ||
CD83 | CD83 molecule | 0.016 | ||
ZIC3 | Zic family member 3 (odd-paired homolog, Drosophila) | 0.016 | ||
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.016 | Human | |
IL2RG | interleukin 2 receptor, gamma | 0.016 | ||
LGALS2 | lectin, galactoside-binding, soluble, 2 | 0.016 | ||
MUC1 | mucin 1, cell surface associated | 0.015 | ||
PHOX2A | paired-like homeobox 2a | 0.015 | ||
MSC | musculin | 0.015 | ||
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.015 | ||
IL1RN | interleukin 1 receptor antagonist | 0.015 | ||
KLF1 | Kruppel-like factor 1 (erythroid) | 0.015 | ||
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.015 | ||
RUNX3 | runt-related transcription factor 3 | 0.015 | ||
AHR | aryl hydrocarbon receptor | 0.015 | ||
HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B | 0.015 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.015 | ||
SMAD4 | SMAD family member 4 | 0.015 | ||
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.015 | ||
AQP5 | aquaporin 5 | 0.015 | ||
HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.014 | ||
RGS16 | regulator of G-protein signaling 16 | 0.014 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.014 | ||
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.014 | ||
ACVR1B | activin A receptor, type IB | 0.014 | Human | |
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.014 | ||
FEV | FEV (ETS oncogene family) | 0.014 | ||
PRRX2 | paired related homeobox 2 | 0.014 | ||
RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.014 | ||
DUOX1 | dual oxidase 1 | 0.014 | ||
WISP1 | WNT1 inducible signaling pathway protein 1 | 0.014 | ||
ACTL8 | actin-like 8 | 0.014 | ||
FGF10 | fibroblast growth factor 10 | 0.014 | ||
C2 | complement component 2 | 0.014 | ||
WISP2 | WNT1 inducible signaling pathway protein 2 | 0.014 | ||
ADRB3 | adrenergic, beta-3-, receptor | 0.014 | ||
ROR2 | receptor tyrosine kinase-like orphan receptor 2 | 0.014 | ||
C11orf10 | chromosome 11 open reading frame 10 | 0.014 | ||
DHH | desert hedgehog | 0.013 | ||
USP15 | ubiquitin specific peptidase 15 | 0.013 | ||
TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.013 | ||
MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.013 | ||
DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.013 | ||
HIPK2 | homeodomain interacting protein kinase 2 | 0.013 | ||
WNT7A | wingless-type MMTV integration site family, member 7A | 0.013 | Human | |
NKX3-2 | NK3 homeobox 2 | 0.013 | ||
SELPLG | selectin P ligand | 0.013 | ||
LAMA5 | laminin, alpha 5 | 0.013 | ||
BMP8B | bone morphogenetic protein 8b | 0.013 | Human | |
ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) | 0.013 | ||
IL9 | interleukin 9 | 0.013 | ||
CH25H | cholesterol 25-hydroxylase | 0.013 | ||
CCL17 | chemokine (C-C motif) ligand 17 | 0.013 | Human | |
CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.013 | ||
POU4F3 | POU class 4 homeobox 3 | 0.013 | ||
TG | thyroglobulin | 0.013 | ||
PLEK | pleckstrin | 0.013 | ||
EIF2D | eukaryotic translation initiation factor 2D | 0.013 | ||
MAPK8 | mitogen-activated protein kinase 8 | 0.013 | ||
DIO3 | deiodinase, iodothyronine, type III | 0.013 | ||
SOX11 | SRY (sex determining region Y)-box 11 | 0.013 | ||
HMX1 | H6 family homeobox 1 | 0.013 | ||
XCR1 | chemokine (C motif) receptor 1 | 0.013 | Human | |
FGF21 | fibroblast growth factor 21 | 0.013 | ||
HIC1 | hypermethylated in cancer 1 | 0.013 | ||
TCF4 | transcription factor 4 | 0.013 | ||
PDX1 | pancreatic and duodenal homeobox 1 | 0.012 | ||
PITX2 | paired-like homeodomain 2 | 0.012 | ||
IL1R2 | interleukin 1 receptor, type II | 0.012 | ||
NPAS1 | neuronal PAS domain protein 1 | 0.012 | ||
MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.012 | ||
HAS2 | hyaluronan synthase 2 | 0.012 | ||
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.012 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.012 | ||
GABRB1 | gamma-aminobutyric acid (GABA) A receptor, beta 1 | 0.012 | ||
FZD10 | frizzled homolog 10 (Drosophila) | 0.012 | ||
ADAM15 | ADAM metallopeptidase domain 15 | 0.012 | ||
PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.012 | ||
AQP9 | aquaporin 9 | 0.012 | ||
SSX4 | synovial sarcoma, X breakpoint 4 | 0.012 | ||
PF4 | platelet factor 4 | 0.012 | ||
OAF | OAF homolog (Drosophila) | 0.012 | ||
HEMGN | hemogen | 0.012 | ||
TRAF1 | TNF receptor-associated factor 1 | 0.011 | ||
CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 0.011 | ||
CDCP1 | CUB domain containing protein 1 | 0.011 | ||
TGFB2 | transforming growth factor, beta 2 | 0.011 | Human | |
SCRT1 | scratch homolog 1, zinc finger protein (Drosophila) | 0.011 | ||
DLX4 | distal-less homeobox 4 | 0.011 | ||
HDAC4 | histone deacetylase 4 | 0.011 | ||
CYP19A1 | cytochrome P450, family 19, subfamily A, polypeptide 1 | 0.011 | ||
CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.011 | ||
PRPH | peripherin | 0.011 | ||
ARRB1 | arrestin, beta 1 | 0.011 | ||
PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.011 | ||
CD160 | CD160 molecule | 0.011 | ||
ZIC1 | Zic family member 1 (odd-paired homolog, Drosophila) | 0.011 | ||
GSC2 | goosecoid homeobox 2 | 0.011 | ||
CYP11B2 | cytochrome P450, family 11, subfamily B, polypeptide 2 | 0.011 | Human | |
VSX1 | visual system homeobox 1 | 0.011 | ||
NEUROG1 | neurogenin 1 | 0.011 | Human | |
TCF21 | transcription factor 21 | 0.011 | ||
POU4F2 | POU class 4 homeobox 2 | 0.011 | ||
LY96 | lymphocyte antigen 96 | 0.011 | ||
CD48 | CD48 molecule | 0.011 | ||
SPOCK2 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 | 0.011 | ||
SOD2 | superoxide dismutase 2, mitochondrial | 0.011 | ||
HOXD11 | homeobox D11 | 0.011 | ||
ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.011 | ||
VAX1 | ventral anterior homeobox 1 | 0.011 | ||
INHBB | inhibin, beta B | 0.011 | ||
ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.011 | ||
FBLN1 | fibulin 1 | 0.011 | ||
ITGB8 | integrin, beta 8 | 0.011 | ||
FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.011 | ||
PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.011 | ||
FOXD3 | forkhead box D3 | 0.011 | ||
SLURP1 | secreted LY6/PLAUR domain containing 1 | 0.011 | ||
HES2 | hairy and enhancer of split 2 (Drosophila) | 0.011 | ||
HOXD13 | homeobox D13 | 0.010 | ||
ICOSLG | inducible T-cell co-stimulator ligand | 0.010 | ||
KREMEN2 | kringle containing transmembrane protein 2 | 0.010 | ||
TBC1D10A | TBC1 domain family, member 10A | 0.010 | ||
GJD2 | gap junction protein, delta 2, 36kDa | 0.010 | ||
TSHB | thyroid stimulating hormone, beta | 0.010 | ||
BMP6 | bone morphogenetic protein 6 | 0.010 | ||
ACAN | aggrecan | 0.010 |